Search Results
New Biological Insights and Novel Strategies in Aggressive B-cell Lymphoma
Dr. Amengual on Novel Therapeutics for B-Cell Lymphoma
ETCTN P10500: a Phase I/expansion study of tazemetostat plus belinostat for R/R NHL
Management of relapse post-alloHSCT in patients with B-cell lymphoma
CNS invasion in B-cell lymphoma: a novel diagnostic and prognostic tool
The important role of bispecific antibodies in the future treatment of R/R DLBCL
3-18-21 - Improving Outcomes in Diffuse Large B-Cell Lymphoma
Blood Review Series – Update on Hodgkin Lymphoma
Key Insights: Lymphoma
Panel discussion on novel therapies and targets for lymphoma
Zamtocabtagene autoleucel (MB-CART2019.1): a novel CAR-T approach in R/R B-NHL
Exploring novel humanized anti-CD19 CAR-T cells as a strategy to minimize CRS and other toxicities
